Recent developments
Portfolio realignment
In its dsm-firmenich Q3 2025 update, the company reported 2% organic sales growth and higher adjusted EBITDA. Full‑year 2025 EBITDA is guided around €2.3 billion, including a €90 million FX headwind and a €50 million reduction from vitamins in Animal Nutrition & Health. The ANH divestment process targets completion in Q4 2025, while about 85% of the €1 billion share buyback was executed by October 28.
Amino acid logistics
Evonik used an Antwerp methionine shutdown to modernize logistics for MetAMINO, adding a new filling installation and expanded storage, and offering 1,000 kg big bags, 25 kg bags, and bulk. The 25 kg format reduces CO2 footprint by 20%. With hubs in Antwerp, Mobile, and Singapore, annual methionine capacity now exceeds 700,000 metric tons to meet rising demand for larger packaging units.
Vitamin formulations
BASF introduced Lutavit A/D3 1000/200 NXT, a microencapsulated combination of vitamins A and D3 produced at Ludwigshafen. It offers stability for premixes and pellets, an 18‑month shelf life under standard storage, and a fixed 5:1 A:D3 ratio with proven vitamin A bioavailability, targeting applicability across species and reflecting development in collaboration with animal nutrition customers.